FMP
E-Qure Corp.
EQUR
PNK
Inactive Equity
E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.
0.0002 USD
-0.0397 (-19850%)
About
ceo
Mr. Ohad Goren
sector
Healthcare
industry
Medical - Devices
website
https://www.e-qure.com
exchange
PNK
Description
E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.
CIK
0001563536
ISIN
US26885P1093
CUSIP
26885P109
Address
20 West 64th Street
Phone
728 916 7333
Country
US
Employee
1
IPO Date
Oct 31, 1994
Summary
CIK
0001563536
Exchange
PNK
Industry
Medical - Devices
Sector
Healthcare
CUSIP
26885P109
ISIN
US26885P1093
Country
US
Price
0
Beta
1.15
Volume Avg.
286
Market Cap
6.91k
Shares
-
52-Week
2.0E-4-0.0499
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.01
P/B
-
Website
https://www.e-qure.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest EQUR News
It looks like there's no news available.
